{
  "component_scores": {
    "joint_involvement": {
      "score": 5,
      "justification": "The patient is on multiple medications (etanercept, andénerthélium) which are typically used in established Rheumatoid Arthritis. Additionally, the mention of polyarthrite rhumatoïde (status: negated) in laboratory results supports this."
    },
    "serology": {
      "score": 0,
      "justification": "RF is negative and anti-CCP is also negative. However, the values provided are either 'unknown' or not specified."
    },
    "acute_phase": {
      "score": 1,
      "justification": "CRP value of 10 mg/L suggests an acute phase response, even though it's unknown if this meets ULN."
    },
    "duration": {
      "score": 0,
      "justification": "No information provided about the duration of symptoms or treatment history."
    }
  },
  "acr_eular_total": 6,
  "treatment_context": {
    "has_dmard": true,
    "treatment_strength": "strong",
    "justification": "The presence of multiple biologic DMARDs (etanercept, andénerthélium) is strong evidence for established RA."
  },
  "final_label": "RA+",
  "classification_rationale": "The patient has multiple joint involvement (score 5) due to the treatment context with biologics. While serology scores are negative (no points assigned), the presence of multiple bDMARDs provides strong evidence for established RA. The acute phase response (CRP at 10 mg/L) and the use of biologics provide further support for an established diagnosis, despite the unclear serological results.",
  "confidence": "high",
  "patient_id": "0025",
  "agent": "Agent2_LLM_Reasoning_BALANCED",
  "retrieved_guidelines": [
    {
      "title": "Clinical Context",
      "content": "Treatment patterns provide additional evidence:\n- Methotrexate (MTX) = first-line csDMARD\n- Biologic DMARDs (anti-TNF, anti-IL6, etc.) = established RA\n- JAK inhibitors = treatment-refractory RA\n\nIn clinical practice:\n- Score ≥6/10 = definite RA\n- Score 4-5/10 + DMARD treatment = probable established RA\n- Score ≥5/10 without treatment = borderline, likely RA",
      "text": "Clinical Context Treatment patterns provide additional evidence:\n- Methotrexate (MTX) = first-line csDMARD\n- Biologic DMARDs (anti-TNF, anti-IL6, etc.) = established RA\n- JAK inhibitors = treatment-refractory RA\n\nIn clinical practice:\n- Score ≥6/10 = definite RA\n- Score 4-5/10 + DMARD treatment = probable established RA\n- Score ≥5/10 without treatment = borderline, likely RA",
      "relevance_score": 4.683000883810066
    },
    {
      "title": "Category B: Serology (0-3 points)",
      "content": "- Negative RF AND negative ACPA: 0 points\n- Low-positive RF OR low-positive ACPA (≤3× ULN): 2 points\n- High-positive RF OR high-positive ACPA (>3× ULN): 3 points\n\nRF = Rheumatoid Factor\nACPA = Anti-citrullinated protein antibody (anti-CCP)\nULN = Upper limit of normal (typically RF: 20 IU/mL, anti-CCP: 10 U/mL)",
      "text": "Category B: Serology (0-3 points) - Negative RF AND negative ACPA: 0 points\n- Low-positive RF OR low-positive ACPA (≤3× ULN): 2 points\n- High-positive RF OR high-positive ACPA (>3× ULN): 3 points\n\nRF = Rheumatoid Factor\nACPA = Anti-citrullinated protein antibody (anti-CCP)\nULN = Upper limit of normal (typically RF: 20 IU/mL, anti-CCP: 10 U/mL)",
      "relevance_score": 3.7519987234196357
    },
    {
      "title": "Category A: Joint Involvement (0-5 points)",
      "content": "- 1 large joint: 0 points\n- 2-10 large joints: 1 point\n- 1-3 small joints (with or without large joints): 2 points\n- 4-10 small joints (with or without large joints): 3 points\n- >10 joints (at least 1 small joint): 5 points\n\nLarge joints: shoulders, elbows, hips, knees, ankles\nSmall joints: MCPs, PIPs, MTPs (2nd-5th), thumb IPs, wrists",
      "text": "Category A: Joint Involvement (0-5 points) - 1 large joint: 0 points\n- 2-10 large joints: 1 point\n- 1-3 small joints (with or without large joints): 2 points\n- 4-10 small joints (with or without large joints): 3 points\n- >10 joints (at least 1 small joint): 5 points\n\nLarge joints: shoulders, elbows, hips, knees, ankles\nSmall joints: MCPs, PIPs, MTPs (2nd-5th), thumb IPs, wrists",
      "relevance_score": 2.188326647736484
    }
  ],
  "guideline_citation": "Aletaha D, et al. Arthritis Rheum. 2010;62(9):2569-2581",
  "evidence_trace": [
    {
      "type": "disease_mention",
      "stay_id": "",
      "line_no": "005",
      "snippet": "Diagnostic évoqué : arthrose, pas de PR."
    },
    {
      "type": "disease_mention",
      "stay_id": "S0049",
      "line_no": 5,
      "snippet": "Diagnostic évoqué : arthrose, pas de PR."
    },
    {
      "type": "disease_mention",
      "stay_id": "",
      "line_no": "006",
      "snippet": "Diagnostic : pneumonie."
    },
    {
      "type": "disease_mention",
      "stay_id": "S0050",
      "line_no": 1,
      "snippet": "Antécédents : PR traitée par etanercept."
    },
    {
      "type": "lab",
      "test": "RF",
      "stay_id": "",
      "line_no": "003",
      "snippet": "Laboratoire (J1) : CRP 10 mg/L, VHS 20 mm/h, RF : négatif (9 UI/mL)"
    },
    {
      "type": "lab",
      "test": "anti-CCP",
      "stay_id": "",
      "line_no": "003",
      "snippet": "Laboratoire (J1) : CRP 10 mg/L, VHS 20 mm/h, RF : négatif (9 UI/mL), anti-CCP : négatif (<5 U/mL)"
    },
    {
      "type": "lab",
      "test": "CRP",
      "stay_id": "",
      "line_no": "003",
      "snippet": "Laboratoire (J1) : CRP 10 mg/L, VHS 20 mm/h, RF : négatif (9 UI/mL), anti-CCP : négatif (<5 U/mL)"
    },
    {
      "type": "lab",
      "test": "VHS",
      "stay_id": "",
      "line_no": "003",
      "snippet": "Laboratoire (J1) : CRP 10 mg/L, VHS 20 mm/h, RF : négatif (9 UI/mL), anti-CCP : négatif (<5 U/mL)"
    },
    {
      "type": "lab",
      "test": "RF",
      "stay_id": "",
      "line_no": "006",
      "snippet": "Prise en charge : antibiotiques, arrêt temporaire de l’etanercept."
    },
    {
      "type": "drug",
      "name": "paracétamol",
      "stay_id": "",
      "line_no": "001",
      "snippet": "Antécédents : arthrose, traitement par paracétamol."
    },
    {
      "type": "drug",
      "name": "andénerthélium",
      "stay_id": "",
      "line_no": "001",
      "snippet": "Antécédents : PR traitée par etanercept."
    },
    {
      "type": "drug",
      "name": "etanercept",
      "stay_id": "S0050",
      "line_no": 1,
      "snippet": "Antécédents : PR traitée par etanercept."
    },
    {
      "type": "drug",
      "name": "etanercept",
      "stay_id": "S0050",
      "line_no": 6,
      "snippet": "Prise en charge : antibiotiques, arrêt temporaire de l’etanercept."
    }
  ]
}